Medicortex International AB (publ) (NGM:MEDFIN)
1.140
0.00 (0.00%)
At close: Aug 26, 2026
NGM:MEDFIN Cash Flow Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -6.07 | -9.56 | -33.14 | -22.44 | -1.06 | -3.21 |
Depreciation & Amortization | 0.53 | 0.42 | 1.52 | 0.99 | 0.44 | 0.42 |
Other Amortization | - | 0.28 | 0.27 | 0.63 | 0.53 | 0.47 |
Other Operating Activities | 0.82 | 4.17 | 24.67 | 12.18 | -4.83 | -0.28 |
Change in Accounts Receivable | 0.21 | 0.18 | -2.04 | -1.92 | 0.15 | 1.77 |
Change in Inventory | 0.25 | 0.2 | 0.55 | -1.32 | -0.65 | -0.08 |
Change in Accounts Payable | 0.22 | - | - | - | - | - |
Change in Other Net Operating Assets | 0.76 | 0.32 | -0.49 | 1.84 | 0.68 | 1.03 |
Operating Cash Flow | -3.29 | -3.98 | -8.66 | -10.05 | -4.73 | 0.11 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | - | - | - | -1.54 | -0.07 | - |
Sale of Property, Plant & Equipment | 5.6 | 5.6 | - | - | - | 0.11 |
Cash Acquisitions | - | - | - | - | -7.8 | 0.41 |
Sale (Purchase) of Intangibles | 0 | -0.02 | -0.65 | -7.02 | -1.52 | -1.13 |
Investment in Securities | -5.7 | -5.72 | -2.31 | -0.91 | -2.7 | 0.6 |
Other Investing Activities | -0.42 | -0.41 | -0.92 | -5.73 | - | - |
Investing Cash Flow | -0.51 | -0.55 | -3.89 | -15.2 | -12.09 | -0.01 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | 0.49 | 1.55 | 10.62 | 2.14 | - |
Long-Term Debt Repaid | - | -1.21 | -3.6 | -1.72 | -1.26 | -1.16 |
Net Debt Issued (Repaid) | 3.42 | -0.72 | -2.05 | 8.9 | 0.88 | -1.16 |
Issuance of Common Stock | 4.86 | 4.86 | 15.1 | 17.16 | 17.98 | 6.75 |
Other Financing Activities | -0 | -0 | -0.97 | -3.99 | -3.85 | -0.42 |
Financing Cash Flow | 8.29 | 4.15 | 12.08 | 22.07 | 15.01 | 5.17 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Miscellaneous Cash Flow Adjustments | - | -0 | - | 0 | 0 | - |
Net Cash Flow | 4.49 | -0.39 | -0.46 | -3.18 | -1.81 | 5.27 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -3.29 | -3.98 | -8.66 | -11.59 | -4.79 | 0.11 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -69.51% | -80.96% | -121.14% | -61.71% | -30.39% | 0.63% |
Free Cash Flow Per Share | -1.19 | -1.63 | -3.93 | -93.11 | -53.02 | 1.64 |
Levered Free Cash Flow | 1.06 | -2.67 | -4.71 | -15.72 | -4.68 | 0.64 |
Unlevered Free Cash Flow | 1.31 | -2.31 | -4.03 | -14.86 | -4.55 | 0.73 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Income Tax Paid | - | - | 0.01 | 0.52 | 0.1 | 0.04 |
Change in Working Capital | 1.43 | 0.7 | -1.98 | -1.4 | 0.19 | 2.72 |